Literature DB >> 393625

Effect of chlorpromazine on the secretory activity of Escherichia coli heat-stable enterotoxin.

D M Abbey, F C Knoop.   

Abstract

The effect of chlorpromazine on the net intestinal accumulation of fluid induced by Escherichia coli heat-stable (ST) enterotoxin in an infant mouse model was examined. Chlorpromazine, when administered with ST enterotoxin, caused a highly significant decrease in net intestinal fluid accumulation. The inhibition of ST activity was dose dependent with various concentrations of chlorpromazine (P less than 0.001). A significant inhibition of toxic activity was also observed when chlorpromazine was administered before (P less than 0.02) or after (P less than 0.05) ST enterotoxin challenge. No significant differences in fluid accumulation were observed between control mice treated with buffer alone and those treated with only chlorpromazine. These data indicate that chlorpromazine markedly decreases the net intestinal fluid accumulation induced by E. coli ST enterotoxin. Further studies on the potential use of chlorpromazine in both the prophylaxis and the treatment of diarrheal diseases appear warranted.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 393625      PMCID: PMC414718          DOI: 10.1128/iai.26.3.1000-1003.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Reversal of cyclic AMP-mediated intestinal secretion in mice by chlorpromazine.

Authors:  J Holmgren; S Lange; I Lönnroth
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

2.  Role of cyclic GMP in the action of heat-stable enterotoxin of Escherichia coli.

Authors:  J M Hughes; F Murad; B Chang; R L Guerrant
Journal:  Nature       Date:  1978-02-23       Impact factor: 49.962

3.  Effect of Escherichia coli heat-stable enterotoxin on cyclic GMP levels in mouse intestine.

Authors:  P M Newsome; M N Burgess; N A Mullan
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

Review 4.  Mechanisms of action of cholera and Escherichia coli enterotoxins.

Authors:  M Field
Journal:  Am J Clin Nutr       Date:  1979-01       Impact factor: 7.045

5.  Nutrition and enterotoxin synthesis by enterotoxigenic strains of Escherichia coli: defined medium for production of heat-stable enterotoxin.

Authors:  J F Alderete; D C Robertson
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

6.  Effect of purified Escherichia coli heat-stable enterotoxin on intestinal cyclic nucleotide metabolism and fluid secretion.

Authors:  R A Giannella; K W Drake
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

7.  Chlorpromazine inhibits cholera toxin-induced intestinal hypersecretion.

Authors:  I Lönnroth; J Holmgren; S Lange
Journal:  Med Biol       Date:  1977-06

8.  Inhibition of the secretory activity of Escherichia coli heat-stable enterotoxin by indomethacin.

Authors:  G L Madsen; F C Knoop
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

9.  Chlorpromazine reverses diarrhea in piglets caused by enterotoxigenic Escherichia coli.

Authors:  I Lönnroth; B Andrén; S Lange; K Martinsson; J Holmgren
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

10.  Chlorpromazine reduces fluid-loss in cholera.

Authors:  G H Rabbani; W B Greenough; J Holmgren; I Lönnroth
Journal:  Lancet       Date:  1979-02-24       Impact factor: 79.321

View more
  9 in total

1.  Failure of chlorpromazine to inhibit fluid accumulation caused by Escherichia coli heat-stable enterotoxin in suckling mice.

Authors:  T Takeda; T Honda; Y Takeda; T Miwatani
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

2.  Reversal of the biological activity of Escherichia coli heat-stable enterotoxin by disulfide-reducing agents.

Authors:  M M ElDeib; C R Dove; C D Parker; T L Veum; G M Zinn; A A White
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

3.  Lanthanum chloride inhibition of the secretory response to Escherichia coli heat-stable enterotoxin.

Authors:  R N Greenberg; F Murad; R L Guerrant
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

4.  Characterization of the mechanism of action of Escherichia coli heat-stable enterotoxin.

Authors:  L A Dreyfus; L Jaso-Friedmann; D C Robertson
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

5.  Inhibition of Escherichia coli heat-stable enterotoxin by indomethacin and chlorpromazine.

Authors:  R N Greenberg; F Murad; B Chang; D C Robertson; R L Guerrant
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

6.  Stimulation of calcium uptake and cyclic GMP synthesis in rat basophilic leukemia cells by Escherichia coli heat-stable enterotoxin.

Authors:  F C Knoop; D D Thomas
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

7.  Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins.

Authors:  R B Sack; J L Froehlich
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

8.  Evaluation of BW942C, a novel antidiarrheal agent, against enterotoxins of Escherichia coli and Vibrio cholerae.

Authors:  D R Morgan; J Sellin; L Gutierrez; H L DuPont; L V Wood
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

Review 9.  Treatment of diarrhea of neonatal calves.

Authors:  A J Roussel; G W Brumbaugh
Journal:  Vet Clin North Am Food Anim Pract       Date:  1991-11       Impact factor: 3.357

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.